HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America. by Flores, I. et al.
481 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
Letters
First Case of Human Ehrlichiosis in
Mexico
To the Editor: Ehrlichiosis is a zoonotic disease
transmitted to humans through the bite of
infected ticks (1). The first recognized human
ehrlichial infection, Sennetsu fever, was de-
scribed in Japan in 1954 (2). The first case of
human ehrlichiosis in the United States was
recognized in 1986 and was reported in 1987 (3).
The disease is caused by intracellular gram-
negative bacteria of the Ehrlichia genus. The
bacteria can be found in the monocytes and
granulocytes of peripheral blood. Human
monocytic ehrlichiosis is caused by E. chafeensis,
and human granulocytic ehrlichiosis is caused by
E. equi or E. phagocytophilia, which was first
recognized in 1994 (4). Most cases occur between
April and September, and the reservoirs are field
animals such as rodents, deer, and dogs. The
clinical spectrum of the disease is similar to that
of other febrile illnesses; without adequate and
timely treatment, approximately 5% of the
patients die (5).
In the United States, more than 400 cases of
serologically confirmed E. chaffensis infection
have been documented since 1996 (6). No cases
have been reported in Mexico.
In February 1997, we evaluated a 41-year-
old male patient from Merida. The patient had
been exposed to ticks during activity in a rural
area 1 week before the onset of illness. Clinical
manifestations included frequent hyperthermia,
rash, myalgia, headache, anorexia, fatigue, and
cough. Physical examination showed bilateral
cervical lymphadenopathy, and a chest radio-
graph showed an interstitial bilateral infiltrate.
Hematic cytometry showed thrombocytopenia
of 134 x 103/µL and 3200 leukocytes (1440
neutrophils/µL). Hepatic transaminases were
elevated, with an aspartate aminotransferase:
92 U/L (normal: 22 U/L), alanine aminotrans-
ferase: 48 U/L (normal: 18 U/L), gamma-
glutamyltranspeptidase: 278 U/L (normal:
28 U/L); and globulins: 4.8 g/dL with a polyclonal
pattern. No antibodies against rickettsia, dengue
virus, B-19 parvovirus, or HIV were detected. A
serum sample gave a positive reaction by indirect
immunofluorescence assay against E. chaffeensis
at titers of 1:64 on week 2 and 1:128 on week 3.
No infected monocytes or granulocytes were
observed in peripheral blood. Remission of the
clinical manifestations began on week 4 and was
completed on week 6.
This case indicates the existence of human
ehrlichiosis in Yucatan, Mexico. Reactivity to
E. chaffeensis suggests human monocytic
ehrlichiosis; however, as antibody testing was
not performed with E. phagocytophila or E. equi,
the possibility of human granulocytic ehrlichiosis
cannot be excluded. In any event, case reports
indicate the need for deliberate search for cases.
Dengue is endemic in this area of Mexico, and
ehrlichiosis should be considered as a differential
diagnosis.
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HIV-1 Subtype F in Single and Dual
Infections in Puerto Rico: A Potential
Sentinel Site for Monitoring Novel Genetic
HIV Variants in North America
To the Editor: Although international efforts to
systematically collect, characterize, and classify
HIV isolates from around the world have
increased considerably, data on HIV-1 genetic
variations in Puerto Rico are limited. This island
(population 3.7 million) has one of the highest482 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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AIDS incidence rates in the United States (53.3
cases per 100,000) (1). To evaluate the potential
for a multiple subtype distribution pattern in
Puerto Rico, we analyzed genetic variations
between HIV-1 strains isolated from peripheral
blood mononuclear cells of 63 asymptomatic
HIV-infected female commercial sex workers
from 12 communities. These participants were
part of 290 female commercial sex workers
followed in a larger cross-sectional study of risk
behavior (2).
HIV-1 subtypes F (n = 4) and B (n = 44)
strains were identified in persons infected with a
single viral subtype with a molecular screening
assay based on restriction fragment length
polymorphism (RFLP) analysis and with DNA
sequencing of the viral protease gene-prot (3).
The remaining 15 specimens were classified by
RFLP as potential dual infections. Further
cloning and sequencing of prot from three of
these specimens confirmed one dual infection
involving subtypes F and B viruses and
identified two infections caused by genetically
distinct quasispecies of subtype B variants.
In further detailed pairwise analysis of HIV-
1 prot genes, a small nucleotide divergence of
0.3% (0.0 to 1.1) within subtype F contrasted
with a typical value of 6.3% (5.1 to 7.8) for the
intrasubtype distance within subtype B prot
sequences (4). The 99% similarity between prot
subtype F Puerto Rican sequences suggested an
epidemiologic link or a recent introduction of
subtype F in Puerto Rico. Comparative sequence
analysis of the C2-V3 env is useful in
establishing the time that elapsed from infection
on the basis of an annual nucleotide divergence
of 0.5% to 1% in this region (5). Such analysis has
been used to study the epidemiologic link
between cases (4,6). Thus, we compared env
sequences from two of five persons infected with
prot subtype F strains. This analysis provided
several observations. Env nucleotide divergence
of 13.2% did not support a direct epidemiologic
link between these strains. Furthermore, the
relatively high intrasubtype diversity between
env sequences suggested that evolution from a
common progenitor would have taken a
minimum of approximately 13 years. Phyloge-
netic analysis classified these two env sequences
as subtype B, indicating that at least some of
Puerto Rican prot subtype F viruses represent
HIV-1 mosaics involving closely related prot F
and significantly divergent env B sequences.
Overall, discrepancy in both subtype assignment
and nucleotide diversities within prot and env
regions may indicate that distinct F/B mosaics
circulating in Puerto Rico were likely the result
of recombination between highly homogeneous
subtype F of relatively recent arrival and
divergent resident subtype B viruses.
HIV-1 infections with subtype F strains
including B/F mosaics have been reported in
Brazil (3,7). To evaluate a potential HIV-1
linkage between Brazil and Puerto Rico, a
comparative phylogenetic analysis was done on
subtype F viral prot sequences from these
countries. This analysis documented that HIV-1
subtype F strains in Puerto Rico are distinct from
both Brazilian and Romanian viruses. Further-
more, our results show that genetic analysis of
prot allows tracking of subtype F viruses of
different origin. Recently, by this approach, HIV-
1 prot subtype F of Puerto Rican origin and F
prot/B env mosaic were identified in HIV-1-
infected persons in New York city (8).
Observation of HIV-1 subtype F strains in Puerto
Rico together with the recent report describing
the first cases of such infections in New York
indicates the potential for further emergence of
subtype F on the North American continent. The
presence of a complex distribution pattern of
subtype F infections in Puerto Rico has serious
implications for the evaluation and development
of HIV diagnostics and vaccines.
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Paratyphoid Fever in India: An Emerging
Problem
To the Editor: Enteric fever is a major public
health problem in India, accounting for more
than 300,000 cases per year, Salmonella typhi is
the most common etiologic agent (1), but
Salmonella paratyphi A, the other causative
agent, causes more asymptomatic infections
than  S. typhi. According to earlier reports from
India,  S. paratyphi A was implicated as a
causative agent in 3%-17% of enteric fever cases
(2). However, a large community-based study in
an urban slum of Delhi during October 1995 to
October 1996 found that S. paratyphi A caused
approximately 20%-25% of the cases of enteric
fever in this region (3). An outbreak of enteric
fever due to a single S. paratyphi A strain in an
urban residential area was reported in 1996 from
New Delhi, where contaminated water was
implicated as the probable source (4,5). This
outbreak prompted a retrospective analysis of
the laboratory records of the All India Institute of
Medical Sciences, New Delhi, over a 5-year
period (1994-1998) to study the change, if any, in
the etiology of enteric fever in North India.
We evaluated all blood culture records from
the institutes clinical bacteriology laboratory for
April to October (the months with the highest
number of enteric fever cases) each year. Records
were from patients residing in New Delhi and the
surrounding areas of North India. The blood was
collected by a phlebotomist in the outpatient
department or by a resident doctor in hospital
wards. Blood cultures were carried out by
standard laboratory technique (6). Five ml of
blood was added to 50 ml of brain heart infusion
broth (Hi-Media Laboratory, India) under
aseptic conditions. Bacterial identification was
accomplished by standard microbiologic protocol
(6). Susceptibility to antibiotics (amoxycillin,
chloramphenicol, cotrimoxazole, gentamicin,
ciprofloxacin, and ceftriaxone) was tested by the
comparative disk diffusion method (Stokes
method) (7). Chi-square for trend was calculated,
and the p value was determined.
The total number of blood cultures per-
formed for enteric fever cases (10,109 in 1994,
12,092 in 1995, 17,652 in 1996, 15,997 in 1997,
and 17,012 in 1998) did not change significantly
over this period. The isolation of S. typhi changed
little (Chi-square = 2.367; p = 0.123; statistically
not significant). However, the proportion of
S. paratyphi A isolates rose from 6.5% in 1994 to
44.9% in 1998 (Chi-square = 22.20; p <0.001;
statistically significant). The proportion of
S. paratyphi A isolations in enteric fever cases
from 1994 to 1998 was 6.5%, 21.2%, 50.5%, 30.7%,
and 44.9%, respectively. Even excluding the
strains from the 1996 outbreak (4), we found that
the proportion of S. paratyphi A in enteric fever
cases increased compared with S. typhi (Chi-
square = 30.528; p <0.001). With our catchment
area,  case definition of enteric fever, and
laboratory methods remaining the same during
this period, it appears that the etiology of enteric
fever in North India is changing significantly.
The age-wise distribution of S. typhi and
S. paratyphi A showed that S. typhi was a
significant isolate from children < 5 years of age,
while this distribution was not observed for
S. parathyphi A, which involved those > 5 years